BioAge Labs Inc

Research BioAge Labs Inc (BIOA) on Bullrun: market cap USD 462.80M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerBIOA
ExchangeNASDAQ
CountryUnited States
SectorHealthcare
IndustryDrug Manufacturers-Specialty & Generic
CurrencyUSD
Market capUSD 462.80M
Financial periodQ2 2026
RevenueUSD 2.45M
Net income-USD 26.10M
Free cash flow-USD 19.59M

Valuation Snapshot

latest market cap is USD 462.80M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	USD 9.00M	-USD 80.61M	-USD 82.35M	n/a	-2.24	USD 188.89M	USD 2.65M	USD 272.05M
FY2024	USD 0	-USD 71.11M	-USD 51.89M	n/a	-6.63	USD 354.35M	USD 8.50M	USD 323.13M
FY2023	n/a	-USD 63.85M	-USD 37.53M	n/a	-38.17	USD 21.64M	USD 14.20M	-USD 173.40M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-25	USD 462.80M	n/a	n/a	n/a
2025	2025-12-31	USD 494.63M	n/a	n/a	n/a
2024	2024-12-31	USD 207.57M	n/a	n/a	n/a

About BioAge Labs Inc

BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging.

Related stock research

United States stocks United States Healthcare stocks A-Z stock index

Other Healthcare stocks

Akebia Therapeutics Inc (AKBA) Amylyx Pharmaceuticals Inc (AMLX) Amphastar Pharmaceuticals Inc (AMPH) Amneal Pharmaceuticals Inc - Class A (AMRX) Anika Therapeutics Inc (ANIK) ANI Pharmaceuticals Inc (ANIP) Apimeds Pharmaceuticals US Inc (APUS) Aquestive Therapeutics Inc (AQST) Assertio Holdings Inc (ASRT) Aytu BioPharma Inc (AYTU) Biocryst Pharmaceuticals Inc (BCRX) Biofrontera Inc (BFRI)

Frequently asked questions

What is BioAge Labs Inc's market cap?

BioAge Labs Inc's market capitalization is USD 462.80M.